Recently, NSF, a globally renowned standards development and certification testing organization, officially awarded Non-GMO Project validation certificates to Weifang Shengtai Pharmaceutical Co., Ltd. for its core products, including glucose, maltodextrin, and crystalline fructose. This successful certification not only authoritatively recognizes Shengtai Pharmaceutical's comprehensive quality control capabilities but also marks a significant milestone for the company in overcoming international export barriers, upgrading its globalization strategy, and seizing opportunities in the global high-end food ingredient market.
As the most credible non-GMO validation system in North America, the Non-GMO Project is committed to building and protecting the global non-GMO food supply chain. Its Butterfly Label is the fastest-growing food label in the US natural products industry and, second only to the USDA organic certification, the most widely recognized food validation label in the North American market. It is also a core entry barrier for food ingredient companies entering the high-end consumer market in North America. During this certification process, NSF, leveraging its deep expertise in the global food industry and its comprehensive technical service capabilities, conducted a rigorous audit of Shengtai Pharmaceutical, covering all aspects from raw material traceability and production control to supply chain isolation and finished product testing. This ensured that the company's entire production and operation chain fully complied with the standards of the Non-GMO Project.
This successful Non-GMO Project certification marks another significant expansion of Shengtai Pharmaceutical's international certification portfolio. As the core enterprise of the Shengtai Group, Weifang Shengtai Pharmaceutical has been deeply involved in the corn deep processing field since its establishment in 1999. It focuses on the research, development, production, and sales of active pharmaceutical ingredients (APIs) such as starch and glucose, as well as pharmaceutical excipients and food ingredients. It now boasts an annual production capacity of 500,000 tons of starch products and 300,000 tons of glucose products, with products widely used in pharmaceuticals, food, papermaking, fine chemicals, and bioengineering. With its superior product quality and comprehensive compliance management capabilities, the company's products not only cover 30 provinces, municipalities, and autonomous regions in China, but are also exported to over 70 countries and regions worldwide. Its pharmaceutical-grade glucose holds over 60% market share in China. The company has received numerous honors, including being named a key leading enterprise in Shandong Province's agricultural industrialization, a hidden champion enterprise, and a benchmark enterprise for intelligent manufacturing in Weifang City.
Prior to this, Shengtai Pharmaceutical had already obtained several authoritative international certifications, including US FDA certification, EU CEP registration, HALAL certification, and KOSHER certification, establishing a complete international compliance system covering both the pharmaceutical and food sectors. The successful implementation of this Non-GMO Project validation will help the company fully meet the core demand for non-GMO raw materials in North America and the global market, fully demonstrate the non-GMO attributes of its products throughout the entire supply chain to downstream customers, effectively break down technical and trade barriers in overseas high-end markets, further expand its international market share, and simultaneously add higher brand value to its products, consolidating the company's industry position in the global starch sugar sector.
In the future, Shengtai Pharmaceutical will continue to adhere to the highest international standards in product quality and compliance system construction, cultivate high-quality and high-value-added product tracks, continuously improve its global certification layout, and provide global customers with more competitive products and solutions through the dual drive of technological innovation and compliance management, thereby continuously promoting the high-quality development and globalization of China's corn deep processing industry.
